Sleep Apnea and Cardiovascular Disease Dr. Javier Nieto , Chair, Dept of Population Health, UW Madison
Dr. Nieto’s main areas of research interest include cardiovascular disease epidemiology, markers of subclinical atherosclerosis, emerging risk factors for cardiovascular disease (homocysteine, inflammation markers, chronic infections), health consequences of sleep disorders and psychosocial stress. He is also interested in methodological issues in epidemiology and in the teaching of epidemiologic methods. Along with Moyses Szklo, he is co-author of a textbook on intermediate epidemiology methods (Epidemiology: Beyond the Basics. Gaithersburg, MD, Aspen Publishers Inc, 2000).
Functional Magnetic Resonance Imaging Dr. Beth Meyerand , Professor Department of Medical Physics, UW Madison
Dr. Meyerand's lab aims to develop new MR methods to visualize the structure and function of the brain and to translate these methods to the hospital for clinical diagnosis. One of their areas of focus is functional MRI (fMRI). FMRI allows for the visualization of both the temporal and spatial patterns of brain activity in response to different stimuli. They are particularly interested in the development of new analysis methods to improve our understanding of brain function. Tour of Waisman Laboratory for Brain Imaging and Behavior.
After hearing from Dr. Meyerand and other faculty members who conduct imaging research, we frequently take a tour of the Waisman Imaging Facility to see the PET and fMRI scanners used to create the images used in data analysis.
Ethical Issues in Clinical Research: The African AZT Trials Dr. Norman Fost , Professor, Pediatrics, UW Madison
Dr. Fost’s interests revolve primarily around issues of ethics in clinical research. Specific interests include ethical and legal issues in research and genetic screening, the use of performance enhancing drugs, access to growth hormone, and the definition of death. A favorite topic for our summer seminar series involves discussion of the African AZT trials.
Biostatistics and the Recruitment and Retention of Under-Represented Minorities in Clinical Trials Dr. DeJuran Richardson , Professor of Mathematics and Computer Science, Director of the Learning and Teaching Center, and Associate Dean of the Faculty, Lake Forest College
Dr. Richardson’s interests are centered in the field of Biostatistics, specifically issues related to clinical trials research. During his seminars in covers important issues in the design and analysis of clinical trials in cancer, infectious diseases and neurological disorders as well as recruiting and retaining African-Americans in clinical trials.
The Role of Biostatisticians in Clinical Trials
Dr. Yili Pritchett , Research Fellow, Director of Clinical Statistics, General Statistics and Data Management, Abbott Laboratories
Dr. Pritchett is an alumna from the UW Madison, receiving her PhD in 1995 from the Department of Statistics with an emphasis in Biostatistics. She is currently Director of Clinical Statistics at Abbot Laboratories. Many PhD’s in Statistics and Biostatistics choose to pursue a job in industry with drug companies a popular choice. In this vein, Dr. Pritchett has been more than willing to share her experience and expertise with our summer students.
Tacos with Dave: Discussing Careers in Biostatistics Dr. David DeMets , Professor, Department of Biostatistics and Medical Informatics, UW Madison
Dr. DeMets personally hosts an event known as Tacos with Dave. Over a dinner of tacos and other delicious Mexican food, students have the opportunity to talk with Dr. DeMets and other faculty about career opportunities in biostatistics. This informal environment allows students the opportunity to freely interact with the faculty and ask questions about how best to further their education and careers.
Biostatistics in the Development and Utilization of Imaging and Radiation Devices Used to Treat Cancer
Tour of TomoTherapy
Eighteen years ago, a team of researchers at the University of Wisconsin-Madison (led by “Rock” Mackie and Paul Reckwerdt) set out to create a new type of cancer radiation delivery system. A publicly-traded company (NASDAQ:TOMO), TomoTherapy Inc. is based in the U.S. with European offices in Belgium and distribution throughout the world. The company owns multiple issued U.S. patents and has a number of patent applications pending, both in the U.S. and worldwide. Students have toured the facility, observing manufacturing and discussing the role that biostatisticians play in the development of this technology.
Biostatistics in the Development and Utilization of Microarray Technology
Tour of Roche NimbleGen
Roche NimbleGen, Inc. (established in 1999) is a leading innovator, manufacturer and supplier of a proprietary suite of DNA microarrays, consumables, instruments and services. Roche NimbleGen uniquely produces high-density arrays of long oligo probes that provide greater information content and higher data quality necessary for studying the full diversity of genomic and epigenomic variation. Scientists can thus obtain a clearer understanding of genomic and epigenomic structure and function and how they impact biology and medicine. This improved performance is made possible by Roche NimbleGen's proprietary Maskless Array Synthesis (MAS) technology which is the result of research collaborations between the departments of biotechnology, genetics, physics, and semiconductor engineering at the University of Wisconsin - Madison. Summer students have toured the facility and heard from scientists the role of biostatistics in the development and utilization of microarray technology.